Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 579.9792 ↑ 0.35%
[as on 14 November, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option -1.15% 0.35% 1.61% 1.87% 0.16% 5.23% 22.67% 18.83% 20.26% 14.62%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.44% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.56%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.29%6256349-
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.26%3083991+14.90%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.01%1000031-
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.48%3495054+9.22%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.92%648795-
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.91%3916074-
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.56%2886684-
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.39%3627277-
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology3.24%1320549-
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.99%913226-
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology2.85%959323-
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.71%2555745-
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.48%68677-
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.34%609112-
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.27%1702630-
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.27%757496-
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.25%1572828-9.29%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services2.20%1029215-
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.16%323678-
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.11%999649-
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.98%4719374+11.66%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.98%318249-
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.43%3896349-
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.35%820020+4.41%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology1.35%303364-
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.32%230272-
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.32%1103889-
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.24%213659-
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.99%1058503-
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.98%1280492-
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.82%1515264-
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology0.74%470272-
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.70%62568-
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.66%1834924-
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology0.43%492727-
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.23%194016-90.30%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.23%111738-
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV history

DateNAV
14 November, 2025579.9792
13 November, 2025577.9789
12 November, 2025575.3141
11 November, 2025570.5733
10 November, 2025572.3607
7 November, 2025570.7980
6 November, 2025574.0441
4 November, 2025577.8362
3 November, 2025579.4970
31 October, 2025571.8029
30 October, 2025573.5529
29 October, 2025576.1216
28 October, 2025571.9440
27 October, 2025573.1177
24 October, 2025573.9228
23 October, 2025576.1432
20 October, 2025577.1389
17 October, 2025573.5263
16 October, 2025572.3997
15 October, 2025569.4740
14 October, 2025569.3600
13 October, 2025572.6294
10 October, 2025572.0801
9 October, 2025566.2688
8 October, 2025562.1867
7 October, 2025564.9499
6 October, 2025563.4696
3 October, 2025561.0231
1 October, 2025559.2785
30 September, 2025553.4629

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 579.9792 as on 14 November, 2025.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -1.15% as on 14 November, 2025.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 5.23% as on 14 November, 2025.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 22.67% as on 14 November, 2025.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.83% as on 14 November, 2025.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.83% as on 14 November, 2025.